APA (7th ed.) Citation

S, Z., H, L., S, S., Y, Z., J, M., Y, L., . . . Y, W. (2022). Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application. Frontiers in pharmacology, 12, 741871. https://doi.org/10.3389/fphar.2021.741871

Chicago Style (17th ed.) Citation

S, Zhang, et al. "Salvia Miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application." Frontiers in Pharmacology 12 (2022): 741871. https://doi.org/10.3389/fphar.2021.741871.

MLA (9th ed.) Citation

S, Zhang, et al. "Salvia Miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application." Frontiers in Pharmacology, vol. 12, 2022, p. 741871, https://doi.org/10.3389/fphar.2021.741871.